11 min read
Monthly FDA Guidance and Regulatory News Review - September 2026
This September 2026 regulatory update focuses on FDA’s new guidance on neonatal parenteral nutrition compounding and...
Extending our scientific depth across allergy, dermatology, ophthalmology, respiratory, women's health, and more.
Learn More →
Every spring, Veristat attends and participates in the MassBio Annual Meeting and 2018 is no different. This year’s event will draw together more than 400 biopharma industry leaders and stakeholders to discuss timely and critical challenges facing the biopharma industry today, not only in Massachusetts, but around the world.
This year’s agenda highlights the following:
Fill out the form on the right hand side of this page to connect with Veristat at this meeting or anytime.
Please visit the MassBio website to get more details or register for this event.
11 min read
Oct 21, 2026 Veristat Blog
This September 2026 regulatory update focuses on FDA’s new guidance on neonatal parenteral nutrition compounding and...
8 min read
Sep 21, 2026 Veristat Blog
This August 2026 regulatory update focuses on the FDA finalizing three guidances addressing formal sponsor meetings,...